RhumbLine Advisers’s MorphoSys AG American Depositary Shares MOR Stock Holding History

RhumbLine Advisers’s Portfolio MOR Stock Details MOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,187	Closed	-$98.3K	–	4220
2024 Q3	$98.3K	Hold	5,187	–	–	﹤0.01%	3500
2024 Q2	$94.4K	Buy	5,187 +785	+18%	+$14.3K	﹤0.01%	3527
2024 Q1	$79.8K	Buy	4,402 +599	+16%	+$8.86K	﹤0.01%	3512
2023 Q4	$37.6K	Buy	3,803 +2,605	+217%	+$19.1K	﹤0.01%	3684
2023 Q3	$8.05K	Buy	1,198 +335	+39%	+$2.58K	﹤0.01%	3905
2023 Q2	$6.45K	Buy	+863	New	+$5.25K	﹤0.01%	4039

RhumbLine Advisers's MOR Position: Q4 2024 in Review

RhumbLine Advisers sold out of MorphoSys AG American Depositary Shares (MOR) in Q4 2024, closing a stake of 5,187 shares — an estimated $98.3K sold.

RhumbLine Advisers first reported a position in MOR in Q2 2023 and held it in 6 quarters. The position peaked at $98.3K in Q3 2024. 0 funds tracked by Wall St. Rank hold MOR as of Q4 2024.

RhumbLine Advisers reported no remaining MorphoSys AG American Depositary Shares position as of Q4 2024 after selling out during the quarter.
RhumbLine Advisers sold 5,187 MorphoSys AG American Depositary Shares shares in Q4 2024, an estimated $98.3K.
RhumbLine Advisers first reported a position in MorphoSys AG American Depositary Shares in Q2 2023 and held it in 6 quarters.
RhumbLine Advisers's MorphoSys AG American Depositary Shares position peaked at $98.3K in Q3 2024.
0 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q4 2024.

Based on RhumbLine Advisers's 13F filing for Q4 2024, filed 30 Jan 2025.